 |
|
|
| |
Sofosbuvir and Ledipasvir Fixed-Dose Combination with and without Ribavirin in Treatment-Naïve and Previously Treated Patients with Genotype 1 Hepatitis C: The LONESTAR Study
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Eric Lawitz1,2, Fred F. Poordad1,2, Phillip S. Pang3,
Robert H. Hyland3, Xiao Ding3, Hongmei Mo3, William T. Symonds3,
John G. McHutchison3, Fernando E. Membreno1,2
1Texas Liver Institute, San Antonio, TX; 2University of Texas Health Science Center, San Antonio, TX; 3Gilead Sciences, Inc, Foster City, CA
|
| |
|
|
|
|
|
